Related Experiment Video
Updated: Jul 1, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
[Non-pharmacologic strategies to prevent and control infectious complications in pediatric hematology/oncology
1Abteilung Pädiatrische Hämatologie/Onkologie, Zentrum für Kinderheilkunde, Medizinische Einrichtungen der Universität Bonn, Germany. Dr.med.A.Simon@t-online.de
Insights
Preventing infections in pediatric cancer patients requires tailored strategies beyond antibiotics. Guidelines focus on reducing exposure and external infection sources, especially during severe neutropenia (low white blood cell count).
Area of Science:
- Pediatric Hematology-Oncology
- Infection Control
- Immunocompromised Patients
Background:
- Infection control is critical for pediatric hematology-oncology patients.
- Prophylactic antibiotic/antifungal regimens are insufficient alone.
- Understanding disease transmission and host risk factors is essential.
Purpose of the Study:
- To overview practical guidelines for preventing infections in immunocompromised children.
- To adjust preventive strategies based on host-specific risk factors like neutropenia.
- To address infection control challenges in pediatric hematology/oncology.
Main Methods:
- Review of practical guidelines for infection prevention.
- Consideration of clinical spectrum and transmission routes.
- Categorization of recommendations by four levels of evidence.
Main Results:
- Guidelines focus on preventing exposure and reducing external infection sources.
- Strategies must account for the degree and duration of immunosuppression.
- Scientific evidence for many measures is limited or incomplete.
Conclusions:
- A systematic and pragmatic approach is needed for infection control.
- Recommendations are categorized by levels of evidence.
- Tailored strategies are fundamental for managing infections in this vulnerable population.
Abstract:
Preventive strategies besides the use of prophylactic antibiotic or antifungal regimens are fundamental ingredients of infection control in pediatric hematology-oncology patients. The clinical spectrum and the routes of transmission of infectious diseases in children have to be considered and preventive strategies should be adjusted to host dependent risk factors, in particular to the degree and duration of severe immunosuppression (i.e. neutropenia). This article overviews practical guidelines to prevent exposure and to reduce external sources of infection in immunocompromised children. Scientific evidence from controlled randomized studies is lacking or incomplete for many of these measures. A systematic and pragmatic approach to the critical control points of patient care in pediatric hematology/oncology is prudent to solve this problem in clinical practice. The corresponding recommendations are categorized in IV different levels of evidence.
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Hand hygiene
Hand washing...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pharmacokinetics in Pediatric Patients: Drug Excretion

